Conversation with The Cancer LetterFree AstraZeneca Exec Discusses Iressa’s Future in the U.S. August 07, 2015Vol.41 No.31By Paul Goldberg
FreeGuest Editorial Kids v Cancer: Laws Need to Catch up to the Science July 30, 2015Vol.41 No.30By Nancy Goodman
Free Baylor Earns Comprehensive Designation; Tisch Institute Becomes NCI Cancer Center July 30, 2015Vol.41 No.30By Matthew Bin Han Ong
Conversation with The Cancer LetterFree The War on Cancer (Drug Prices): Political Education of Hagop Kantarjian July 30, 2015Vol.41 No.30By Paul Goldberg
FDA & NCI Create Unique Jobs Combining Regulatory Science with Clinical Expertise July 24, 2015Vol.41 No.29By Matthew Bin Han Ong
FreeLetter To The Editor NCCS: Covering End-of-Life Planning is a Step Toward Delivering Patient-Centered Care July 17, 2015Vol.41 No.28By Shelley Fuld Nasso
Iressa Returns to U.S. Market— Now with Companion Diagnostic July 17, 2015Vol.41 No.28By Paul Goldberg
Free MD Anderson Faculty White Paper To UT Chancellor Calls for Executive Pay Freeze, Elimination of “Two-Class System” July 13, 2015Vol.41 No.28By Matthew Bin Han Ong
